Terms: = Pancreatic cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Clinical Outcome
2 results:
1. NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and bcrp promotes breast cancer progression.
Zhao CC; Sun X; Chen J; Geng BD
Thorac Cancer; 2024 Apr; 15(10):820-829. PubMed ID: 38409918
[TBL] [Abstract] [Full Text] [Related]
2. Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome.
Tanaka M; Okazaki T; Suzuki H; Abbruzzese JL; Li D
Cancer; 2011 Feb; 117(4):744-51. PubMed ID: 20922799
[TBL] [Abstract] [Full Text] [Related]
